...
首页> 外文期刊>Genetics and Molecular Research >Two novel ATP2C1 mutations in patients with Hailey-Hailey disease and a literature review of sequence variants reported in the Chinese population
【24h】

Two novel ATP2C1 mutations in patients with Hailey-Hailey disease and a literature review of sequence variants reported in the Chinese population

机译:Hailey-Hailey病患者的两个新的ATP2C1突变和中国人群中报道的序列变异文献综述

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Hailey-Hailey disease (HHD) is an autosomal dominant disorder in which the ATP2C1 gene has been implicated. Many mutations of this gene have been detected in HHD patients. To analyze such mutations in HHD and summarize all those identified in Chinese patients with this disease, we examined four familial and two sporadic cases and searched for case reports and papers by using the Chinese Biological Medicine Database and PubMed. HHD diagnoses were made based on clinical features and histopathological findings. Polymerase chain reaction and direct sequencing of the ATP2C1 gene were performed using blood samples from HHD patients, unaffected family members, and 120 healthy individuals. Three mutations were identified, including the recurrent mutation c.2126CT (p.Thr709Met), and two novel missense mutations, c.2235_2236insC (p.Pro745fs*756) and c.689GA (p.Gly230Asp). Considering our data, 81 different mutations have now been reported in Chinese patients with HHD. In cases of misannotation or duplication, previously published mutations were renamed according to a complementary DNA reference sequence. These mutations are scattered throughout the ATP2C1 gene, with no evident hotspots or clustering. It is of note that some reported “novel” mutations were in fact found to be recurrent. Our findings expand the range of known ATP2C1 sequence variants in this disease.
机译:Hailey-Hailey病(HHD)是一种常染色体显性遗传疾病,其中涉及ATP2C1基因。在HHD患者中已检测到该基因的许多突变。为了分析HHD中的此类突变并总结在中国患有这种疾病的患者中发现的所有突变,我们检查了四个家族性病例和两个散发性病例,并使用中国生物医学数据库和PubMed搜索了病例报告和论文。根据临床特征和组织病理学发现进行HHD诊断。聚合酶链反应和ATP2C1基因的直接测序是使用HHD患者,未受影响的家庭成员和120位健康个体的血液样本进行的。鉴定出三个突变,包括复发突变c.2126C> T(p.Thr709Met),和两个新的错义突变c.2235_2236insC(p.Pro745fs * 756)和c.689G> A(p.Gly230Asp)。考虑到我们的数据,目前在中国的HHD患者中报告了81种不同的突变。在出现错误注释或重复的情况下,先前发表的突变会根据互补的DNA参考序列进行重命名。这些突变散布在整个ATP2C1基因中,没有明显的热点或聚类。值得注意的是,实际上发现某些报告的“新”突变是经常性的。我们的发现扩大了该疾病中已知的ATP2C1序列变异的范围。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号